Trials of a Covid-19 vaccine being developed by AstraZeneca and Oxford University will resume after being paused due to a reported side effect in a patient in the UK. On Tuesday, AstraZeneca said the studies were being paused while it investigated whether the adverse reaction was linked with the vaccine. But on Saturday, the university… Read More »
U.S. drugmaker Pfizer and German biotech BioNTech said they began their late-stage human trial for a potential coronavirus vaccine on Monday as pharmaceutical companies race to win regulatory approval before the end of the year. Shares of Pfizer rose more than 3% in after-hours trading Monday. BioNTech was up more than 2%. The trial will include up… Read More »
With megablockbuster Humira on the decline, AbbVie is hoping for big things from its next-gen JAK inhibitor Rinvoq. Now, in a head-to-head rheumatoid arthritis battle with Bristol Myers Squibb’s blockbuster Orencia, Rinvoq has come out on top. Rinvoq matched Bristol’s Orencia in easing rheumatoid arthritis patients’ symptoms at the 12-week mark and bested its older rival in patient remission rates, according to… Read More »
Monday was supposed to be the day when four pharmaceutical companies appeared as defendants in a trial that sought to litigate their culpability in the opioid epidemic. Instead, those companies reached a settlement Monday morning totaling $ 260 million, multiple sources confirm. The four companies in question — AmerisourceBergen Corp., Cardinal Health, McKesson Corp. and… Read More »
In a bid to improve user experience and bring Instagram back to what it should be—a place to connect and positively share content without worrying how many ‘likes’ you’re going to get and competing with others, the social media platform today has introduced its second phase in a global test which works to disable the… Read More »